Abbott Laboratories (NYSE:ABT) : Net money flow in Abbott Laboratories (NYSE:ABT) was negative ($21.16 million) and the inflow of money on uptick was $39.3 million, whereas, the outflow of money on downticks amounted to $60.47 million on Wednesday. The traders used every opportunity of price strength in the stock to sell their positions, hence, the total uptick to downtick ratio was 0.65. The block trades show that the large investors, were aggressive sellers in the stock. The total value of block trades on upticks was only $4.08 million. On the other hand, the total value of block trades done on downticks was $20.33 million. The ratio of uptick to downtick block trades was 0.2. The money flow in block trades was negative ($16.26). Abbott Laboratories (NYSE:ABT) gained $1.01 cent during the day and reached $38.57, a gain of 2.69% over the previous day.
In an insider trading activity,The officer (Senior Vice President) of Abbott Laboratories, Watkin Jared sold 552 shares at $37.63 on June 15, 2016. The Insider selling transaction had a total value worth of $20,772. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing. Currently the company Insiders own 0.26% of Abbott Laboratories shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -0.81% . Institutional Investors own 69.95% of Abbott Laboratories shares.
The company shares have dropped -24.15% from its 1 Year high price. On Jul 23, 2015, the shares registered one year high at $51.74 and the one year low was seen on Jan 28, 2016. The 50-Day Moving Average price is $38.25 and the 200 Day Moving Average price is recorded at $40.23. Abbott Laboratories (NYSE:ABT): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $37.95 and $37.95 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $38.75. The buying momentum continued till the end and the stock did not give up its gains. It closed at $38.57, notching a gain of 2.69% for the day. The total traded volume was 8,366,480 . The stock had closed at $37.56 on the previous day.
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a range of health care products. Abbott operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment includes the sales of a line of adult and pediatric nutritional products. The Nutritional Products includes the sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary, endovascular, structural heart, vessel closure and other medical device products.